Longevity biotech is now a market.
The Longevity Biotech Report 2026 tracks 3,036 assets across 781 companies and projects a $617BN annual market by 2045.
Read it here:
Sponsored by MuseCell Innovations:
#LongevityBiotech#
Longevity is often mocked as a 'billionaire obsession'. Let's remember that every major technology always begins as expensive, and with time it improves and becomes more accessible. Don't believe me?
The first consumer color TV (1954) cost approx: $12,000 (adjusted for inflation)
Today, a TV with features unimaginable at that time can be found for $200+
Chi Longevity goes beyond bloodwork with cognitive, dual-task and psychological assessments. This reflects @AndreaBMaier’s concept of biological youthfulness, supporting cognitive, functional and physical capacity throughout life.
#ChiLongevity#
Chi Longevity’s three flagship programmes combine comprehensive assessments with physician-led care from physicians, dietitians, psychologists and health coaches, recognising that healthy longevity requires more than a single test.
#ChiLongevity#
Chi Longevity’s Maier Method, developed by @AndreaBMaier, connects genetic, epigenetic, metabolic, inflammatory and microbiome data to understand how biological systems interact, rather than relying on a single biological-age score.
#ChiLongevity#
Indian longevity company has moved from lab work to launch, turning a December funding round into new products and diagnostics.
#longevity# #india# #diagnostics# #biotech# #aging#
@DecodeAge